These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 11194241)
1. Potential short-term economic benefits of improved glycemic control: a managed care perspective. Menzin J; Langley-Hawthorne C; Friedman M; Boulanger L; Cavanaugh R Diabetes Care; 2001 Jan; 24(1):51-5. PubMed ID: 11194241 [TBL] [Abstract][Full Text] [Related]
2. Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus. Menzin J; Korn JR; Cohen J; Lobo F; Zhang B; Friedman M; Neumann PJ J Manag Care Pharm; 2010 May; 16(4):264-75. PubMed ID: 20433217 [TBL] [Abstract][Full Text] [Related]
3. The cost to health plans of poor glycemic control. Gilmer TP; O'Connor PJ; Manning WG; Rush WA Diabetes Care; 1997 Dec; 20(12):1847-53. PubMed ID: 9405905 [TBL] [Abstract][Full Text] [Related]
4. Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UK. Bain SC; Bekker Hansen B; Hunt B; Chubb B; Valentine WJ J Med Econ; 2020 Jan; 23(1):98-105. PubMed ID: 31311364 [No Abstract] [Full Text] [Related]
5. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962 [TBL] [Abstract][Full Text] [Related]
6. The Association Between Sustained HbA1c Control and Long-Term Complications Among Individuals with Type 2 Diabetes: A Retrospective Study. Boye KS; Thieu VT; Lage MJ; Miller H; Paczkowski R Adv Ther; 2022 May; 39(5):2208-2221. PubMed ID: 35316502 [TBL] [Abstract][Full Text] [Related]
7. Health and economic effects of adding nateglinide to metformin to achieve dual control of glycosylated hemoglobin and postprandial glucose levels in a model of type 2 diabetes mellitus. Salas M; Ward A; Caro J Clin Ther; 2002 Oct; 24(10):1690-705. PubMed ID: 12462297 [TBL] [Abstract][Full Text] [Related]
8. Effect of improved glycemic control on health care costs and utilization. Wagner EH; Sandhu N; Newton KM; McCulloch DK; Ramsey SD; Grothaus LC JAMA; 2001 Jan; 285(2):182-9. PubMed ID: 11176811 [TBL] [Abstract][Full Text] [Related]
9. Assessment of glycemic control using glycated hemoglobin among diabetic patients in Jimma University specialized hospital, Ethiopia. Cheneke W; Suleman S; Yemane T; Abebe G BMC Res Notes; 2016 Feb; 9():96. PubMed ID: 26879899 [TBL] [Abstract][Full Text] [Related]
11. Usefulness of glycated hemoglobin A1c-based adjusted glycemic variables in diabetic patients presenting with acute ischemic stroke. Yang CJ; Liao WI; Wang JC; Tsai CL; Lee JT; Peng GS; Lee CH; Hsu CW; Tsai SH Am J Emerg Med; 2017 Sep; 35(9):1240-1246. PubMed ID: 28363620 [TBL] [Abstract][Full Text] [Related]
12. Glycemic control paradox: Poor glycemic control associated with higher one-year and eight-year risks of all-cause hospitalization but lower one-year risk of hypoglycemia in patients with type 2 diabetes. Li TC; Kardia SL; Li CI; Chen CC; Liu CS; Yang SY; Muo CS; Peyser PA; Lin CC Metabolism; 2015 Sep; 64(9):1013-21. PubMed ID: 26026367 [TBL] [Abstract][Full Text] [Related]
13. Health care costs in people with diabetes and their association with glycemic control and kidney function. McBrien KA; Manns BJ; Chui B; Klarenbach SW; Rabi D; Ravani P; Hemmelgarn B; Wiebe N; Au F; Clement F Diabetes Care; 2013 May; 36(5):1172-80. PubMed ID: 23238665 [TBL] [Abstract][Full Text] [Related]
14. Impact of Perioperative HbA1c on Reimbursements in Diabetes Mellitus Patients Undergoing Total Hip Arthroplasty: A Nationwide Analysis. Kurowicki J; Rosas S; Khlopas A; Newman JM; Law TY; Roche MW; Higuera CA; Mont MA J Arthroplasty; 2018 Jul; 33(7):2038-2042. PubMed ID: 29891083 [TBL] [Abstract][Full Text] [Related]
15. What are the clinical, quality-of-life, and cost consequences of 30 years of excellent vs. poor glycemic control in type 1 diabetes? Herman WH; Braffett BH; Kuo S; Lee JM; Brandle M; Jacobson AM; Prosser LA; Lachin JM J Diabetes Complications; 2018 Oct; 32(10):911-915. PubMed ID: 30082172 [TBL] [Abstract][Full Text] [Related]
16. Effect of short- and long-term diabetes control on in-hospital and one year mortality rates in hospitalized patients with diabetic foot. Feldbrin Z; Shargorodsky M; Wainstein J; Melnikov D; Zandman-Goddard G Eur J Intern Med; 2018 May; 51():29-33. PubMed ID: 29329893 [TBL] [Abstract][Full Text] [Related]
17. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9. Weng J J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564 [TBL] [Abstract][Full Text] [Related]
18. The impact of glycemic variability on length of stay and mortality in diabetic patients admitted with community-acquired pneumonia or chronic obstructive pulmonary disease. Ferreira L; Moniz AC; Carneiro AS; Miranda AS; Fangueiro C; Fernandes D; Silva I; Palhinhas I; Lemos J; Antunes J; Leal M; Sampaio N; Faria S Diabetes Metab Syndr; 2019; 13(1):149-153. PubMed ID: 30641688 [TBL] [Abstract][Full Text] [Related]
19. OPEN ACCESS TO DIABETES CENTER FROM THE EMERGENCY DEPARTMENT REDUCES HOSPITALIZATIONS IN THE SUSEQUENT YEAR. Palermo NE; Modzelewski KL; Farwell AP; Fosbroke J; Shankar KN; Alexanian SM; Baker WE; Simonson DC; McDonnell ME Endocr Pract; 2016 Oct; 22(10):1161-1169. PubMed ID: 27732094 [TBL] [Abstract][Full Text] [Related]
20. Association between glycemic control and short-term healthcare costs among commercially insured diabetes patients in the United States. Aagren M; Luo W J Med Econ; 2011; 14(1):108-14. PubMed ID: 21241161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]